• Home
  • » Healthcare
  • » Whole Exome Sequencing Consumption Market, 2016 | Industry Report

Whole Exome Sequencing Consumption Industry 2016 Market Research Report

Report ID: MN17613866  |  Published: September 2016  |  No of Pages: 106
Format: Electronic (PDF)  |  Industry: Healthcare  |  Publisher: QY Research

Global Whole Exome Sequencing Consumption Market is segmented, By Product Type into Agilent Halo Plex, Agilent Sure Select, Roche Nimblegen SeqCap, MicroarraysMy baits, Agilent Sure Select QXT, and Illumina TruSeq Exome. Exome sequencing is a technique used for strategically sequencing all the protein coding genes in a genome known as exome. In other words, the complete DNA sequence of the whole organism’s genome for single time by using various laboratory processes is known as the Whole Exome Sequencing. For therapeutic intervention, the whole genome sequence plays an important role..

There are 1,80,000 exons, which establish about 1 % of the human genome. The whole exome sequencing technique is widely used for the Miller syndrome and Alzheimer’s disease. Whole Exome Sequencing Consumption Market is segmented, By Application into Mendelian disease and rare syndrome gene discovery, The research of complex diseases, Mouse exome sequencing. The North American region consists of the U.S., and Canada. Latin American region consists of Mexico and Brazil. The Western European region consists of Germany, Italy, France, England and Spain. The Eastern European region consists of Poland and Russia. Asia Pacific region consists of China, India, ASEAN, Australia & New Zealand. The Middle East and Africa region consists of GCC, South Africa, and North Africa. 

North America is followed by the Europe and Asia region due to the R&D in these regions, and Asia-Pacific is anticipated to grow at a significant rate in the years to come. Global Whole Exome Sequencing Consumption Market Key Players include Illumina, Thermos Fisher, Roche, Agilent, Microgen, BGI, Novo Gene, Eurofins, Sengenics, and Ambry. The companies are focusing on mergers, acquisitions, and joint ventures to survive in the competition. “Survival of the fittest” is the dictum followed by the major market players all over.

This report studies Whole Exome Sequencing in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
• Illumina
• Thermo Fisher
• Roche
• Angilent
• Eurofins
• Sengenics
• Ambry
• Macrogen
• Novo Gene

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Whole Exome Sequencing in these regions, from 2011 to 2021 (forecast), like
• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
• Agilent HaloPlex
• Agilent SureSelect
• Agilent SureSelect QXT
• Illumina TruSeq Exome
• Roche Nimblegen SeqCap
• MYcroarray MYbaits

Split by application, this report focuses on consumption, market share and growth rate of Whole Exome Sequencing in each application, can be divided into
• Mendelian disease and rare syndrome gene discovery
• The research of complex diseases
• Mouse exome sequencing

What questions do you have? Get quick response from our industry experts. Request More information
Key questions answered in the report include
We also offers customization on reports based on specific client requirement.
Request for Customization

Select a format

Research Assistance

Ryan Manuel

Research Support Specialist, USA

  1. Phone: 1-408-610-2300
  2. Toll Free: 1-866-831-4085
  3. Email: [email protected]
  • World's largest premium report database
  • Transparent pre & post sale customer engagement model
  • Unparalleled flexibility in terms of rendering services
  • Safe & secure web experience
  • 24*5 Research support service
  • 100% Secure Payments
  • Our Promise
  • 100% Service Assurance
  • Market Monitoring
  • Service Flexibility
  • 24X5 Care available